Alder Matthias Insider Trades

Insider Trading History

Track insider trading activity for Alder Matthias. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Gain Therapeutics
Gain Therapeutics GANX
Chief Executive Officer
Holding Value $37.8k 21,140 shares
Last Trade
Mar 26, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$24.7k 6,085 shares
$4.06
$1.79
Gain Therapeutics
Gain Therapeutics GANX
Chief Executive Officer
Holding Value $662k 370,000 shares
Last Trade
Mar 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.62M 370,000 shares
$4.37
$1.79
Gain Therapeutics
Gain Therapeutics GANX
Chief Executive Officer
Holding Value $9.46k 5,286 shares
Last Trade
Dec 21, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$507 206 shares
$2.46
$1.79
Gain Therapeutics
Gain Therapeutics GANX
Chief Executive Officer
Holding Value $9.83k 5,492 shares
Last Trade
Dec 20, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.55k 637 shares
$2.44
$1.79
Gain Therapeutics
Gain Therapeutics GANX
Chief Executive Officer
Holding Value $12.6k 7,013 shares
Last Trade
Dec 20, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.55k 637 shares
$2.44
$1.79
Gain Therapeutics
Gain Therapeutics GANX
Chief Executive Officer
Holding Value $8.69k 4,855 shares
Last Trade
Dec 07, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.55k 1,820 shares
$2.50
$1.79
Gain Therapeutics
Gain Therapeutics GANX
Chief Executive Officer
Holding Value $11.9k 6,675 shares
Last Trade
Oct 01, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.71k 825 shares
$3.28
$1.79
Gain Therapeutics
Gain Therapeutics GANX
Chief Executive Officer
Holding Value $16.2k 9,075 shares
Last Trade
Oct 01, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.71k 825 shares
$3.28
$1.79
Gain Therapeutics
Gain Therapeutics GANX
Chief Executive Officer
Holding Value $10.5k 5,850 shares
Last Trade
Sep 20, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$8.67k 2,550 shares
$3.40
$1.79
Gain Therapeutics
Gain Therapeutics GANX
Chief Executive Officer
Holding Value $13.7k 7,650 shares
Last Trade
Sep 20, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$8.67k 2,550 shares
$3.40
$1.79
Gain Therapeutics
Gain Therapeutics GANX
Chief Executive Officer
Holding Value $17.7k 9,900 shares
Last Trade
Jul 01, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$14.8k 3,300 shares
$4.48
$1.79
Gain Therapeutics
Gain Therapeutics GANX
Chief Executive Officer
Holding Value $5.91k 3,300 shares
Last Trade
Jul 01, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$14.8k 3,300 shares
$4.48
$1.79
Gain Therapeutics
Gain Therapeutics GANX
Chief Executive Officer
Holding Value $269k 150,000 shares
Last Trade
Mar 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$726k 150,000 shares
$4.84
$1.79
Gain Therapeutics
Gain Therapeutics GANX
Chief Operating Officer
Holding Value $142k 79,200 shares
Last Trade
Jul 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$318k 79,200 shares
$4.01
$1.79
Gain Therapeutics
Gain Therapeutics GANX
CHIEF OPERATING OFFICER
Holding Value $358k 200,000 shares
Last Trade
Dec 23, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.17M 200,000 shares
$5.86
$1.79

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up